HALO logo
halo search icon
NEIMETH
Neimeth International Pharmaceuticals PLC

NEIMETH · Neimeth International Pharmaceuticals PLC

8.50

NGN
0.00 (0.00%)
23/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

NGN36.32B

PE

25.40

EV/EBITDA

22.8

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 23/06/2026 12:00:00 AM

Price Chart

Description

Neimeth International Pharmaceuticals Plc engages in the manufacture and marketing of pharmaceuticals, animal health products, and general health products. It operates through the Pharmaceuticals Product Group and Animal Health Product Group segments. The Pharmaceuticals Product Group segment includes the marketing and sale of the firm's branded products, and the consumer product group. The Animal Health Product Group segment covers the marketing and sale of poultry and large animal range of anthelmintic, as well as production enhancing medicaments. The company was founded on August 13, 1957 and is headquartered in Ikeja, Nigeria.

  • All-Companies
  • HALO 100
  • HALO All
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-206.80%

EBITDA Margin

19.50%

Operating Cashflow

₦192m

Free Cash Flow Return

3.30%

ROIC

16.90%

Interest Coverage

1.10

Quick Ratio

0.80

Performance

52 weeks range

Low 4.12 - 14.2

Trade Value (12mth)

US$8,582.00

1 week

0.59%

1 month

-22.73%

YTD

56.34%

1 year

172.9%

All time high

14.20

Additional Data

Shares Outstanding (Fully Diluted)

4,273m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

NGN

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Neimeth International Pharmaceuticals PLC (NEIMETH:NSA)?
Halo FAQ
The current share price of Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) is NGN₦8.50.
2
What is the 52-week high share price for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA)?
Halo FAQ
The 52-week high share price for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) is NGN₦14.20.
3
What is the 52-week low share price for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA)?
Halo FAQ
The 52-week low share price for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) is NGN₦4.12.
4
What is the dividend yield for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA)?
Halo FAQ
Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) does not pay a dividend.
5
What was Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) last dividend payment?
Halo FAQ
The last dividend payment of Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) is NGN₦0.07.
6
What is the franking level for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA)?
Halo FAQ
Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) has a franking level of 0.00%.
7
In which sector is Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) classified?
Halo FAQ
Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA)?
Halo FAQ
The current P/E ratio for Neimeth International Pharmaceuticals PLC (NEIMETH:NSA) is 25.40.